Viewing Study NCT00821535


Ignite Creation Date: 2025-12-24 @ 10:15 PM
Ignite Modification Date: 2026-03-24 @ 7:52 AM
Study NCT ID: NCT00821535
Status: COMPLETED
Last Update Posted: 2010-11-16
First Post: 2009-01-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese Volunteers
Sponsor: ViiV Healthcare
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A4001084
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Director, Clinical Trial Disclosure Group
Old Organization: Pfizer, Inc.

Collaborators

Collaborators

Name Class View
None INDUSTRY View